United States Autoimmune Disorders Diagnostics Market Report

1. India Adhesives Market Forecast & Opportunities, 2020 Market Opportunities, 2020 United States Autoimmune Disorders Diagnostics P h a r m a & H e a l t h c a r e C o n s u l t a n t s

2. Re s e a rc h M e t h o d o l o g y United States Autoimmune Disorders Diagnostics Market Secondary Sources Primary Sources •Government websites •Company annual reports, white papers, investor presentations and financial reports •Identifying Key Opinion Leaders •Questionnaire Design •In-depth Interviews •Coverage across Value Chain market Data Collection Qualitative and Quantitative Research Data Validation, Analysis and Interpretation Data validation through Primary & Secondary outreach, data analysis and interpretation of key findings Market Estimation & Forecasting Bottom-Up or Top-down approach for Market size estimation Historical trend examination Impact analysis of drivers and challenges to market growth Statistical evaluation to develop the actual forecast CAGR (2015E-2020F): XX% 7 © Pharmaion 2 2015E 2016F 2017F 2018F 2019F 2020F

3. Re s e a rc h M e t h o d o l o g y Baseline Methodology: For the study of United States autoimmune disorders diagnostics market, Pharmaion has gathered information through an exhaustive search of credible databases prudently evaluated all the collected information and presented it in the most accurate and detailed manner. Primary Research Qualitative and quantitative data from company website, financial reports, research articles, designed questionnaires etc. Key Stakeholders:  Product/Brand Managers  Business Development Managers  Regional Mangers  Regulatory Affairs Personnel  Marketing & Sales Managers  Head of Patient Support Programme In-depth interviews of key stakeholders of major companies Data Triangulation (Data validation through cross verification from primary & secondary sources) Secondary Research Analysis of Data from credible sources:  Centers for and Prevention (CDC)  WHO Reports  American Related Diseases Association (AARDA)  American Rheumatology  National Institute of Arthritis and Musculoskeletal and Skin Diseases Disease Control Autoimmune College of Substantial data points for analysis, interpretation and market size estimation 3 © Pharmaion

4. Re s e a rc h M e t h o d o l o g y United States Autoimmune Disorders Diagnostics Market - Market Size Estimation  United States autoimmune disorders diagnostics market has been segmented into two segments: systemic autoimmune disorders diagnostics and localized autoimmune disorders diagnostics.  Further, the United States autoimmune disorders diagnostics market has been categorized into seven sub-segments: Anti-Nuclear Antibody Test, Complete Blood Count Test, Erythrocyte Sedimentation Rate (ESR), C-reactive protein, Comprehensive Metabolic Panel, Urinalysis and Others  Anti-Nuclear antibody tests market have been further classified into three sub segments: ENA Panel, Anti-dsDNA and Others (Anticentromere Antibody, Histone Antibody, Nucleolar Antibody, etc.). Calculation of market size of the US autoimmune disorders diagnostics market CAGR of forecast period obtained from the primary and secondary outreach applied on the given market Top-down Approach By Target Disease, Test & Technology Market Size = Respective Market Share (From Primary and Secondary Research) X Total Market Value Calculation of Sub- segment market size Calculation of regional market size Regional Market Size = Respective Market Share (From Primary and Secondary Research) X Total Market Value 4 © Pharmaion

5. Ta b l e o f C o n te n t s S No. Contents 1. Autoimmune Disorders Diagnostics Overview 2. Research Methodology 3. Analyst View 4. Disease Epidemiology 4. Global Autoimmune Disorders Diagnostics Market Overview 5. United States Autoimmune Disorders Diagnostics Market Outlook 5.1. Market Size & Forecast 5.1.1. By Value 5.2. Market Share & Forecast By Target Disease (Systemic Autoimmune Disorders Diagnostics & Localized Autoimmune Disorders Diagnostics) 5.2.1. By Test (Urinalysis, Comprehensive Metabolic Panel, C-reactive Protein, Erythrocyte Sedimentation Rate, Complete Blood Count, Anti-Nuclear Antibody Test & Others) 5.2.2. By Technology (Enzyme Immunoassay, Multiplexed Immunoassays, Immunofluorescence & Others) 5.2.3. 5.2.4. By Region (South-West, West, North-East, Midwest, South-East) 6. United States Anti-Nuclear Antibody Test Market Outlook 6.1. Market Size & Forecast 6.1.1. By Value 6.2. Market Share & Forecast By Type {Others (Anti-centromere Antibodies, Histone Antibody & Nucleolar Antibody), Anti- dsDNA Test & ENA Panel} 6.2.1. 7. Market Dynamics 7.1. Drivers 5 7.2. Challenges © Pharmaion

6. Ta b l e o f C o n te n t s S No. Contents 8. Market Trends & Developments 8.1. Increasing Use of Biomarkers 8.2. Lab automation 8.3. Lab-on- Chip Device 8.4. Portable Diagnostic Equipment 8.5. Partnership with Physician and Diagnostic Laboratories 9. Policy & Regulatory Landscape 10. United States Economic Profile 11. Competitive Landscape 11.1. Competition Benchmarking (Market Attractiveness) 11.2. Company Profiles 11.2.1. Bio-Rad Laboratories, Inc. 11.2.2. Roche Diagnostics Corporation 11.2.3. Abbott Laboratories 11.2.4. Danaher Corporation 11.2.5. Siemens Healthcare Diagnostics, Inc. 11.2.6. Biomeriux Clinical Diagnostics 11.2.7. Immco Diagnostics 11.2.8. Beckton Dickson 11.2.9. Alere Inc. 11.2.10. Inova Diagnostics, Inc. 12. Strategic Recommendations 3 13. About Us & Disclaimer © Pharmaion

7. I n d u s t r y B r i e f United States Autoimmune Disorders Diagnostics Market to Surpass US$ 6 Billion by 2020 Growing prevalence of autoimmune disorders and various ongoing technological advancements to drive the United States autoimmune disorders diagnostics market According to recently published Pharmaion report, “United States Autoimmune Disorders Diagnostics Market Opportunities, 2020”,the autoimmune disorders diagnostics market in the United States is anticipated to cross US$ 6 billion by 2020. Some of the major autoimmune diseases include Rheumatoid Arthritis, Type 1 Diabetes, Multiple Sclerosis, Systemic Lupus Erythematosus (SLE), Inflammatory Bowel Disease (IBD), Psoriasis and Autoimmune Thyroiditis, etc. According to American Autoimmune Related Diseases Association (AARDA), 50 million Americans are suffering from more than 100 types of autoimmune disorders, and 75-85% of the total autoimmune disorders patients in the country are women. Growth in the market is anticipated on account of growing disease burden of various autoimmune disorders, increasing healthcare expenditure and various ongoing technological advancements. Moreover, increasing automation in laboratories leading to precise and faster diagnosis is forecast to further fuel the market of autoimmune disorders diagnostics in the United States during 2015 - 2020.On the basis of target disease, the market is broadly segmented into two categories, namely, systemic autoimmune disorders diagnostics and localized autoimmune disorders diagnostics. Among these two categories, systemic autoimmune disorders diagnostics segment dominated the United States autoimmune disorders diagnostics market in 2014, and the segment is anticipated to continue its dominance through 2020 on account of increasing ongoing research activities that are focused on developing tests and technologies that would precisely detect the abnormalities in organ functioning and deliver faster diagnosis. “With growing adoption of biomarkers, Lab-on-Chip devices and portable diagnostic equipment, the market for autoimmune disorders diagnostics in the United States is anticipated to grow over the next five years. Moreover, National Institute of Allergy and Infectious Diseases (NIAID) is organizing a clinical research program - Autoimmunity Centre of Excellence (ACEs) for effective diagnosis and treatment of autoimmune diseases by expanding collaborative research across medical specialties, scientific disciplines, and basic & clinical scientists.", said Mr. Karan Chechi, Research Director of Pharmaion, a research based global pharmaceutical and healthcare consulting firm. 7 © Pharmaion

8. P ro d u c t O ve r v i e w Autoimmune disorders occur when a person’s immune system attacks his/her own body; and for detecting these disorders and prescribing required treatments, various laboratory tests are performed. On the basis of disorder type, autoimmune disorders diagnostics market in the US has been segmented into two categories, namely, systemic autoimmune disorders diagnostics and localized autoimmune disorders diagnostics. Autoimmune Disorders Diagnostics Market Localised Autoimmune Disorders Diagnostics Systemic Autoimmune Disorders Diagnostics Systemic Autoimmune Disorders Diagnostics: They are non-organ specific disease which affects multiple organs and tissues of the body is known as systematic autoimmune disorder. It broadly involves the diagnosis of diseases, such as Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis, Ankylosing Spondylitis, etc., which are mainly diagnosed by rheumatologists and clinical immunologists. Localised Autoimmune Disorders Diagnostics: They are organ specific disease which effects single organ or tissue of the body and are diagnosed mainly by rheumatologists, endocrinologists and neurologists. It mainly involves the diagnosis of diseases like Multiple Sclerosis, Inflammatory Bowel Disease (IBD), Type 1 Diabetes, Thyroid, etc. 6 © Pharmaion

9. Sample Data - Snapshot United States Average Annual Cost of Diagnosis and United States Autoimmune Disorders Diagnostics Market Share, By Test, Treatment of Autoimmune Disorders, 2014 By Value, 2010-2020F 35.10% 35.09% 35.08% 35.07% 35.06% 35.05% 35.04% 35.03% 35.02% 35.01% 35.00% Autoimmune Disorder Annual Cost* per Patient (USD) X X 17.10% 17.09% 17.08% 17.07% 17.06% 17.05% 17.04% 17.03% 17.02% 17.01% 17.00% X X 14.10% 14.09% 14.08% 14.07% 14.06% 14.05% 14.04% 14.03% 14.02% 14.01% 14.00% X X 9.10% 9.09% 9.08% 9.07% 9.06% 9.05% 9.04% 9.03% 9.02% 9.01% 9.00% X X 8.10% 8.09% 8.08% 8.07% 8.06% 8.05% 8.04% 8.03% 8.02% 8.01% 8.00% 6.10% 6.09% 6.08% 6.05% 6.07% 6.04% 6.06% 6.03% 6.02% 6.01% 6.00% X X 3.0… 3.10% 3.09% 3.04% 3.05% 3.06% 3.07% 3.02% 3.03% 3.00% 3.08% 2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F United States Autoimmune Disorders Diagnostics Anti-Nuclear Antibody Test Erythrocyte Sedimentation Rate (ESR) Complete Blood Count (CBC) C-reactive Protein Market Size, By Value, 2010-2020F (USD Billion) 12 11 10 9 8 7 United States Autoimmune Disorders Diagnosis Market 5 4 3 2 1 Share, By Region, By Value, 2014 & 2020F 2010 2011 2012 2013 2014 2015E2016F2017F2018F2019F2020F West North- East Midwest SEGMENTAL REVENUE BREAK UP, 2014 By Business Segments 2014: X% 2020F: X% By Geography 2014: X% 2020F: X% 2014: X% 2020F: X% Life Unites States, 50.00% Other Countries, 50.00% Science, 50.00% Clinical Diagnosti cs, 50.00% United States Autoimmune Disorders Prevalence per 150 100,000 Population, 2013 100 South- East 2014: X% 2020F: X% 50 South- West 9 2014: X% 2020F: X% Diabetes Type 1 Systemic Lupus Erthymatosus (SLE) Rheumatoid Arthritis © Pharmaion

10. Re p o r t O rd e r i n g Report Name: United States Autoimmune Disorders Diagnostics Market Opportunities, 2020 Report Price License Type Price Single User License $3000 Single User License Print $3500 Enterprise License $5000 To View Sample OR Purchase Report 10 ©

11. A b o u t U s & D i s c l a i m e r About Us : Pharmaion is a research based management consulting firm focused exclusively on Healthcare & Pharmaceutical industry. Pharmaion’s core values are value, integrity and insight. Led by a team of dynamic industry experts, Pharmaion provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, Pharmaion’s clients lead rather than follow market trends. Not bound by legacy, Pharmaion’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, Pharmaion’s reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients. Pharmaion is committed to assisting customers worldwide with their unique market research needs by providing them with comprehensive, value-added solutions and professional market intelligence services. Pharmaion employs the industry’s best-trained industry Analysts and Consultants, which advises and assists customers in meeting their full service market research and consulting requirements. Related Reports India Stem Cell Market Opportunities, 2020 Global Tissue Engineered Medical Devices Market Opportunities, 2020 Global Cervical Cancer Vaccine Market Opportunities, 2020 Disclaimer : The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or complete. Pharmaion Consultants has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable and first hand. However, Pharmaion Consultants does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior approval of Pharmaion Consultants. NORTH AMERICA Pharmaion Consultants LLC 708 3RD Avenue, 6th Floor, New York, NY, United State, 10017 sales@pharmaion.com +1 646 360 1656 www.pharmaion.com ASIA PACIFIC Pharmaion Consultants Pvt. Ltd. A – 51, Sector 57, Noida, National Capital Region, India - 201301 sales@pharmaion.com +91 - 120 - 452 3900 www.pharmaion.com 11 © Pharmaion